|
MCM3APAS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.285000380719E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.57830000472259E-08 |
| Normal-vs-Stage2 |
1.95229999999658E-05 |
| Normal-vs-Stage3 |
1.38240000002732E-06 |
| Normal-vs-Stage4 |
8.67189997588724E-09 |
| Stage1-vs-Stage2 |
7.418800E-01 |
| Stage1-vs-Stage3 |
9.152600E-01 |
| Stage1-vs-Stage4 |
2.172500E-02 |
| Stage2-vs-Stage3 |
6.945000E-01 |
| Stage2-vs-Stage4 |
1.559640E-01 |
| Stage3-vs-Stage4 |
3.660100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.99039961868675E-10 |
| Normal-vs-AfricanAmerican |
2.794300E-02 |
| Normal-vs-Asian |
9.83860000000059E-05 |
| Caucasian-vs-AfricanAmerican |
4.532400E-01 |
| Caucasian-vs-Asian |
5.844400E-01 |
| AfricanAmerican-vs-Asian |
6.513000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10379999976418E-07 |
| Normal-vs-Female |
9.45510003624861E-09 |
| Male-vs-Female |
4.664400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.78350000049166E-07 |
| Normal-vs-Age(41-60Yrs) |
3.5717000024249E-08 |
| Normal-vs-Age(61-80Yrs) |
1.65210000013793E-07 |
| Normal-vs-Age(81-100Yrs) |
4.671700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.092000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.428400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.055000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.857200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.378200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.491800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.803900E-02 |
| Classical-VS-Follicular |
4.175200E-01 |
| Classical-VS-Other |
6.105800E-01 |
| Classical-VS-Normal |
2.95390000237816E-08 |
| Tall-VS-Follicular |
1.242580E-01 |
| Tall-VS-Other |
5.101600E-01 |
| Tall-VS-Normal |
5.58280000007016E-08 |
| Follicular-VS-Other |
8.399200E-01 |
| Follicular-VS-Normal |
2.10759999996757E-06 |
| Other-VS-Normal |
2.750000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.75160000235064E-09 |
| Normal-vs-N1 |
3.52519999999856E-05 |
| N0-vs-N1 |
6.758600E-01 |
|
|
